First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...

Topline data were announced from 2 phase 3 trials evaluating MR-107A-02 for the treatment of moderate to severe acute pain.

Topline data were announced from two phase 3 trials evaluating MR-107A-02 for the treatment of moderate to severe acute pain.

PME-1 is a protein that modifies other proteins by removing methyl groups, but high levels of PME-1 are observed in some ...

Di-2-ethylhexylphthalate contributes to 13.497% of all cardiovascular deaths among individuals aged 55 to 64 years with considerable geographic disparities.

Pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer and the fourth leading cause of cancer-related death, has a 5-year survival rate of less than 10%.1 The impact of pancreatic ...

Q1 2025 Management View Rick Pauls, President and CEO, stated that "we continue to make substantial progress in both of our ...